Linear Source Registry for Prostate Cancer

NCT02516709 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-09-08

No results posted yet for this study

Summary

Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.

Conditions

Interventions

RADIATION

Linear LDR Source

The Linear LDR source is a permanent interstitial brachytherapy implant containing palladium-103 sources for the treatment of prostate cancer.

Sponsors & Collaborators

  • CivaTech Oncology

    lead INDUSTRY

Principal Investigators

  • Kristy Perez, PhD · CivaTech Oncology

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02516709 on ClinicalTrials.gov